Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
B-Plex is a sterile injectable vitamin B complex formulation developed by Merit Pharmaceuticals. It contains a combination of essential B vitamins, typically including thiamine (B1), riboflavin (B2), niacinamide (B3), pyridoxine (B6), and dexpanthenol (B5). These vitamins serve as vital precursors for coenzymes involved in numerous metabolic pathways, such as the citric acid cycle and the electron transport chain, which are critical for energy production and cellular maintenance. The product is indicated for the treatment and prevention of vitamin B deficiencies in patients who cannot tolerate oral intake or have severe malabsorption issues, such as those with chronic alcoholism, severe illness, or post-operative recovery needs. By providing these micronutrients parenterally, B-Plex ensures rapid availability for cellular processes, supporting neurological function, skin integrity, and overall metabolic homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin b complex (Merit Pharmaceutical).